What is the Transparency Council going to do on April 4?
The Medical Research Agency has launched a competition dedicated to entrepreneurs for financing the development, performance and clinical evaluation of innovative medical devices, for which it will allocate PLN 100 million. The call for applications lasts from March 30, 2022 to June 30, 2022.
Google has some plans for us. The company wants to use smartphones to monitor health - it will record the rhythm of the heartbeat and look ... deep into our eyes. This is to help you recognize health problems.
Prostate cancer is the most common oncological disease among men in Poland. Every year, this disease affects nearly 16,000 men, of which as many as of them die. The detection of prostate neoplasms is relatively easy. For diagnostics, only blood tests and a visit to the urologist are necessary. To...
What will the Transparency Council do on March 21?
The Chief Sanitary Inspector issued a decision on the nationwide recall of the medicinal product: Vigantol (Cholecalciferolum), 500 µg/ml (20,000IU/ml), oral drops, solution, lot number 19KQ193, expiry 10.2024. The responsible entity is P&G Health Germany GmbH. The decision was made immediately...
Two pharmaceutical companies, Pfizer and Bayer, have confirmed that they will keep humanitarian drug deliveries to Russia, but will withdraw from other activities in the country.
Domestic pharmaceutical companies associated in the Polish Association of Pharmaceutical Industry Employers donated almost one million drug packages to Ukraine, worth approximately PLN 15 million.
In view of the ongoing Russian invasion of Ukraine and the influx of refugees, we need to find systemic solutions as soon as possible to legally and efficiently provide these people with medical care. An essential element is ensuring access to drugs. As an industry, we declare the willingness to...
Janssen - the pharmaceutical company Johnson & Johnson - has signed a cooperation agreement with the Warsaw Health Innovation Hub.
The health department published: Announcement of the Minister of Health of February 21, 2022 on the list of drugs and foodstuffs for particular nutritional uses for which an official selling price has been established Announcement: HERE Announcement of the Minister of Health of February 21, 2022...
On the website of the Ministry of Health, a Draft announcement of the Minister of Health on the list of reimbursed drugs, foodstuffs for particular nutritional uses and medical devices has been published, which will enter into force on March 1, 2022. Comments to the draft Notice of the Minister...
Scientists at National Robotarium, a partnership between Heriot-Watt University and Edinburgh University, industrial partners and Edinburgh clinicians are developing a new robotic surgery technique to improve cancer outcomes and patient care . The groundbreaking method has won a £ 1.25 million...
The agenda for the Transparency Council (02/14) includes: Preparation of an opinion on the validity of introducing Vocabria (cabotegravir), used in combination with rilpivirine, into the health policy program "Antiretroviral treatment of people living with HIV in Poland". Preparation of a...
In an interview between Medexpress and professor Marek Wojtukiewicz, head of the Oncology Clinic, Medical University in Białystok, we asked about the unmet needs of patients suffering from pancreatic cancer and about the challenges faced by doctors dealing with this group of oncological patients....
- We will be changing drug programs comprehensively - said Deputy Minister of Health Maciej Miłkowski during the Hearing of the Social Forum of Patients' Organizations and announced further good changes in hemat-oncology.
Sanofi has unveiled a new unified corporate brand. This is the effect of the transformation initiated in December 2019.
Iwona Schymalli's guest is prof. Lidia Gil from the Department and Clinic of Hematology and Bone Marrow Transplantation at the Medical University.
There is a communication from the Ministry of Health on the submission of applications for reimbursement consent pursuant to Art. 39 of the Act of 12 May 2011 on the reimbursement of drugs, foodstuffs for particular nutritional uses and medical devices - regarding drugs imported from abroad as...
We talk to Dr. Iwona Skoneczna from the National Institute of Oncology. Maria Skłodowska-Curie National Research Institute, Grochowski Hospital Rafał Masztak, MD, PhD.
The agenda of the Republic of Poland on February 7 includes: Preparation of a position on drug evaluation: Imbruvica (ibrutinibum) under the drug scheme: B.92. "Treatment of patients with chronic lymphocytic leukemia with ibrutinib (ICD-10: C91.1), Opdivo (nivolumabum) as part of the drug...
The Council of the EU today adopted a regulation amending the mandate of the European Medicines Agency (EMA) as part of the ongoing work to create a strong European Health Union. This is an important step towards strengthening the EMA in crisis preparedness and management for medicinal products...
The agenda for the Transparency Council, which will meet on January 31st, is: Preparation of positions on drug evaluation: Venclyxto (venetoclaxum) as part of the drug program: "Treatment of patients with acute myeloid leukemia with venetoclax in combination with azacitidine (ICD-10 C92.0)",...
The US Food and Drug Administration has approved the use of the biological medicine frunevetmab to treat pain in cats suffering from osteoarthritis. It is the first of its kind to be approved by the FDA for use in an animal species.
The agenda includes: Preparation of positions on the evaluation of the drug Emgality (galcanezumabum) under the drug program: "Prophylactic treatment of patients with chronic migraine (ICD-10: G43)". Preparation of an opinion on the reimbursement of drugs containing the active substance...
The Presidium of the Supreme Medical Council, after reviewing the draft ordinance of the President of the National Health Fund on the terms of concluding and implementing contracts such as hospital treatment in the field of drug programs, submits the following comments to the draft ordinance. The...
The agenda is: Preparation of positions on drug evaluation: Inrebic (fedratinibum) under the drug program: "Treatment of primary myelofibrosis and secondary myelofibrosis in the course of polycythemia vera and essential thrombocythemia (ICD-10 D47.1)", Kesimpta (ofatumumabum) under the drug...
The European Commission (EC) has granted conditional marketing authorisation for sotorasib, a first-in-class KRASG12C inhibitor, for the treatment of adults with advanced non-small cell lung cancer (NSCLC) with KRAS G12C mutation and who have progressed after at least one prior line of systemic...
The draft ordinance of the Minister of Health amending the ordinance on enriching substances added to food was submitted for consultation.
The Council will meet on January 10 (Monday). The agenda is: Preparation of a position on the evaluation of the drug Jardiance (empagliflozinum) in the indication: chronic heart failure in adult patients with reduced left ventricular ejection fraction (LVEF ≤ 40%) and persistent disease symptoms...
© 2023 Medexpress. All Rights Reserved
